These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18888)

  • 21. Discussion of serotonin and dopamine in the extrapyramidal system.
    Andén NE
    Adv Pharmacol (1962); 1968; 6(Pt A):347-9. PubMed ID: 4969659
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of cocaine on extrapyramidal and limbic dynorphin systems.
    Smiley PL; Johnson M; Bush L; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):938-43. PubMed ID: 1972755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system.
    Lammel S; Hetzel A; Häckel O; Jones I; Liss B; Roeper J
    Neuron; 2008 Mar; 57(5):760-73. PubMed ID: 18341995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-specific blockade of dopamine receptors by neuroleptic agents in human brain.
    Borison RL; Fields JZ; Diamond BI
    Neuropharmacology; 1981 Dec; 20(12B):1321-2. PubMed ID: 6119643
    [No Abstract]   [Full Text] [Related]  

  • 25. Neurotransmitter interactions related to central dopamine neurons.
    Lloyd KG
    Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of lesion of mesolimbic dopamine neurons on pain threshold and morphine analgesia in rats.
    Szreniawski Z; Mészáros J; Gajewska S; Tarchalska-Kryńska B
    Pol J Pharmacol Pharm; 1977; 29(5):521-5. PubMed ID: 22847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic studies of tardive dyskinesia.
    Chase TN; Tamminga CA
    Adv Biochem Psychopharmacol; 1980; 24():457-61. PubMed ID: 7405673
    [No Abstract]   [Full Text] [Related]  

  • 28. Dopaminergic, GABA-ergic and cholinergic interaction in the regulation of striatal acetylcholine concentration.
    Sethy VH
    Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):359-62. PubMed ID: 358340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of pipothiazine palmitate on CNS structures: neurophysiological and behavioral and behavioral correlations.
    Guerrero-Figueroa R; Guerrero-Figueroa E; Gallant DM; De la Vega H
    Curr Ther Res Clin Exp; 1974 Jun; 16(6):659-68. PubMed ID: 4152576
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neuroleptics and extrapyramidal effects from the biochemical viewpoint. Discussion by the Workshop on Neuroleptics and the Extrapyramidal System].
    Seyfried C
    Arzneimittelforschung; 1978; 28(9):1537-8. PubMed ID: 38815
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the role of dopaminergic systems in morphine-induced motor activity. Comparison with noradrenergic and cholinergic systems.
    VanderWende C; Spoerlein MT; Can Luc N
    Res Commun Chem Pathol Pharmacol; 1975 May; 11(1):79-88. PubMed ID: 1153864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropharmacology of the extrapyramidal system.
    Borison RL; Diamond BI
    J Clin Psychiatry; 1987 Sep; 48 Suppl():7-12. PubMed ID: 3305490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of antipsychotic drugs.
    Borison RL
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):25-8. PubMed ID: 2858475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of the discharges of sympathetic and parasympathetic nerves during stimulation of the visceral field of the limbic cortex].
    Baklavadzhian OG; Bagdasarian KG; Eganova VS; Kasparova SR; Khachatrian AV
    Fiziol Zh SSSR Im I M Sechenova; 1989 Feb; 75(2):161-70. PubMed ID: 2721759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chronic neuroleptic treatment on tyrosine hydroxylase in dopaminergic terminals: comparisons between drugs and brain regions reveals different mechanisms of tolerance.
    Gale K
    Adv Biochem Psychopharmacol; 1980; 24():23-9. PubMed ID: 6105777
    [No Abstract]   [Full Text] [Related]  

  • 36. Mesocorticolimbic dopaminergic network: functional and regulatory roles.
    Le Moal M; Simon H
    Physiol Rev; 1991 Jan; 71(1):155-234. PubMed ID: 1986388
    [No Abstract]   [Full Text] [Related]  

  • 37. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 38. Computer analysis of interacting dopaminergic and cholinergic control mechanisms in the extrapyramidal system.
    Gough AL; Gough NE
    Int J Biomed Comput; 1978 Mar; 9(2):81-100. PubMed ID: 738802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The laminar distribution of the neuronal sources of afferent fibers to the neocortex in the caudal regions of the limbic cortex in rats and cats].
    Tolkunov BF; Nomokonova LM; Afanas'ev SV; Sologub NIa
    Zh Evol Biokhim Fiziol; 1993; 29(1):69-75. PubMed ID: 8498115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmitters for the afferent and efferent systems of the neostriatum and their possible interactions.
    Kim JS
    Adv Biochem Psychopharmacol; 1978; 19():217-33. PubMed ID: 29447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.